Arrow Generics, a Watson Company, launches Quetiapine Tablets upon patent expiry.
Posted on 24th Mar 2012
Arrow Generics, a Watson Company, are proud to announce the launch of Quetiapine Tablets on day 1 of patent expiry. The film-coated tablets are available in 25mg, 100mg, 150mg, 200mg and 300mg in packs of 60.
Quetiapine is the generic version of Seroquel® and is indicated for the:
· Treatment of schizophrenia.
· Treatment of moderate to severe manic episodes.
· Treatment of major depressive episodes in bipolar disorder.
This launch marks the 5th consecutive Patent Expiry launch for Arrow. Previous day 1 launches in 2012 include Latanoprost, Donepezil, Zolmitriptan and Naratriptan.
If you require further information please contact us via the web page.